Healthcare -
Biotechnology - NASDAQ - US
$ 0.6658
-6.33 %
$ 195 M
Market Cap
-0.84
P/E
LYEL - CAPITAL EXPENDITURES
Capital Expenditures LYEL - Lyell Immunopharma, Inc.
-2.69 M
LAST VALUE
79.75%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR